Detalles de la búsqueda
1.
Exercise training improves neurovascular control and calcium cycling gene expression in patients with heart failure with cardiac resynchronization therapy.
Am J Physiol Heart Circ Physiol
; 311(5): H1180-H1188, 2016 11 01.
Artículo
Inglés
| MEDLINE | ID: mdl-27591218
2.
Functional IL18 polymorphism and susceptibility to Chronic Chagas Disease.
Cytokine
; 73(1): 79-83, 2015 May.
Artículo
Inglés
| MEDLINE | ID: mdl-25743241
3.
Effects of cardiac resynchronization therapy on muscle sympathetic nerve activity.
Pacing Clin Electrophysiol
; 37(1): 11-8, 2014 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-23952584
4.
CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial.
Am Heart J
; 166(6): 976-982.e4, 2013 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-24268211
5.
Sudden cardiac death in Brazil: study based on physicians' perceptions of the public health care system.
Pacing Clin Electrophysiol
; 35(11): 1326-31, 2012 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-22946554
6.
Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical forms.
Front Immunol
; 13: 1020572, 2022.
Artículo
Inglés
| MEDLINE | ID: mdl-36248819
7.
Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy.
Front Immunol
; 13: 958200, 2022.
Artículo
Inglés
| MEDLINE | ID: mdl-36072583
8.
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Europace
; 18(2): 159-83, 2016 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-26585598
9.
Implantable cardioverter-defibrillator efficacy in Chagas disease patients depends not only on the device performance: optimizing the adjunct therapy is essential.
Europace
; 16(6): 939, 2014 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-24671167
10.
Mitochondrial DNA haplogroups and variants predispose to chagas disease cardiomyopathy
Hearts
; 4(4): 97-117, dez.2023. ilus
Artículo
Inglés
| CONASS, SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1530621
11.
Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical forms
Front. immunol
; 13(1020572): 1-6, Sept. 2022. graf
Artículo
Inglés
| CONASS, SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1396604
12.
Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy
Front. immunol
; 13(958200): 01-16, Aug. 2022. graf, ilus, tab
Artículo
Inglés
| CONASS, SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1400349
13.
Complications after Surgical Procedures in Patients with Cardiac Implantable Electronic Devices: Results of a Prospective Registry.
Arq Bras Cardiol
; 107(3): 245-256, 2016 Sep.
Artículo
Inglés, Portugués
| MEDLINE | ID: mdl-27579544
14.
Erratum to '2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-deï¬brillator programming and testing' [Journal of Arrhythmia 32/1 (2016) 1-28].
J Arrhythm
; 32(5): 441-442, 2016 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-27761170
15.
COMBAT--conventional versus multisite pacing for bradyarrhythmia therapy: rationale of a prospective randomized multicenter study.
Eur J Heart Fail
; 7(2): 219-24, 2005 Mar 02.
Artículo
Inglés
| MEDLINE | ID: mdl-15701470
16.
Improved relationship between left and right ventricular electrical activation after cardiac resynchronization therapy in heart failure patients can be quantified by body surface potential mapping.
Clinics (Sao Paulo)
; 68(7): 986-91, 2013 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-23917664
17.
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
Am J Cardiol
; 110(7): 1040-5, 2012 Oct 01.
Artículo
Inglés
| MEDLINE | ID: mdl-22727179
18.
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Heart Rhythm
; 13(2): e50-86, 2016 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-26607062
19.
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
J Arrhythm
; 32(1): 1-28, 2016 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-26949427
20.
Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
Circ Arrhythm Electrophysiol
; 2(1): 29-34, 2009 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-19808441